SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-19-002358
Filing Date
2019-08-29
Accepted
2019-08-29 20:05:42
Documents
1
Period of Report
2019-08-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form410109001_08292019.html 4  
1 OWNERSHIP DOCUMENT form410109001_08292019.xml 4 3843
  Complete submission text file 0000921895-19-002358.txt   5266
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEMORIAL SLOAN KETTERING CANCER CENT 1275 YORK AVENUE, BOX 524 NEW YORK NY 10065
Business Address
Raskin Gregory S (Reporting) CIK: 0001753646 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 191067610